Head-To-Head Analysis: Mazor Robotics (MZOR) and IRIDEX (IRIX)

Mazor Robotics (NASDAQ: MZOR) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Volatility and Risk

Mazor Robotics has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, IRIDEX has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500.

Institutional and Insider Ownership

26.4% of Mazor Robotics shares are held by institutional investors. Comparatively, 49.3% of IRIDEX shares are held by institutional investors. 5.0% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.


This table compares Mazor Robotics and IRIDEX’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mazor Robotics -28.80% -22.68% -18.29%
IRIDEX -42.22% -23.21% -19.03%

Valuation & Earnings

This table compares Mazor Robotics and IRIDEX’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mazor Robotics $36.38 million 41.25 -$18.66 million ($0.70) -84.01
IRIDEX $46.16 million 1.90 -$11.71 million ($1.70) -4.45

IRIDEX has higher revenue and earnings than Mazor Robotics. Mazor Robotics is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations for Mazor Robotics and IRIDEX, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mazor Robotics 2 5 1 0 1.88
IRIDEX 0 0 1 0 3.00

Mazor Robotics presently has a consensus target price of $40.00, suggesting a potential downside of 31.98%. IRIDEX has a consensus target price of $13.00, suggesting a potential upside of 71.73%. Given IRIDEX’s stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Mazor Robotics.


IRIDEX beats Mazor Robotics on 8 of the 13 factors compared between the two stocks.

Mazor Robotics Company Profile

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

IRIDEX Company Profile

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company’s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply